| Factor | Score | Distribution | Value | Avg | Rank |
|---|---|---|---|---|---|
Valuation | 6 | 78.9x | 17.8x | Bottom tier | |
Growth | 35 | 8.5% | 7.1% | Bottom tier | |
Quality | 24 | 0.6% | 4.5% | Bottom tier | |
Safety | 41 | — | 2.6x | Around median | |
Capital Return | 11 | — | 2.12% | Bottom tier | |
Momentum | 24 | -8.3% | 2.9% | Bottom tier | |
Sentiment | 81 | 9 | 3 | Top tier |
Estimates — analyst targets and a simplified DCF, not investment advice.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.
Centrus Energy operates in uranium enrichment and nuclear fuel services through two main segments: the LEU segment, which sells low-enriched uranium and separative work unit services, SWU, and the Technical Solutions segment, which includes HALEU activities and government technical contracts. The company targets three interconnected markets: LEU fuel for commercial reactors, U.S. national security needs, and HALEU fuel for advanced reactors, while partially funding the expansion of its domestic capacity through cash flows from its brokerage business, government contracts, and customer prepayments.
In Q2 of fiscal 2026, revenue reached $176.1 million, an increase of 14% year over year, and gross profit was $49.9 million, with a gross margin of approximately 28.3%. The LEU segment generated revenue of $153.4 million, or about 87% of total revenue, up 22% year over year, compared with $22.7 million for Technical Solutions, or about 13%, down 21% year over year. The LEU segment's results included uranium sales of $53.4 million, while the volume of SWU sold declined 23% and its average price increased 3%.
Net income in Q2 of fiscal 2026 was approximately $16.8 million and diluted earnings per share were $0.77, compared with net income of $28.9 million and earnings per share of $1.59 in Q2 of fiscal 2025. Operating income was $10.4 million, while adjusted net income reached $38.7 million and adjusted earnings per share were $1.77. For comparison, fiscal 2025 recorded revenue of $448.7 million, gross profit of $117.5 million, and net income of $77.8 million.
Automated analysis for informational purposes only — not investment advice.
The analyst consensus on LEU is Neutral, with an average price target of $225 and a wide range between $185 and $300; the average is below the 52-week high of $464.25, and the highest analyst target itself is also below that level. No published price-to-earnings ratio is available, so the valuation depends more heavily on executing the $4.5 billion backlog and converting expansion investments into production capacity in 2029, weighed against the risks of margin pressure, significant capital expenditures, and stock volatility within a 52-week range of $142.13 to $464.25.
Figures in the text are as of 2026-08-31; the live price is shown at the top of the page.
Centrus Energy generated total revenue of $176.1 million in Q2 of fiscal 2026. The LEU segment contributed approximately $153.4 million, or about 87% of the total, and its results included $53.4 million from uranium sales. The Technical Solutions segment recorded $22.7 million, or about 13% of revenue, after a year-over-year decline of 21% primarily associated with the HALEU operations contract.
The backlog reached $4.5 billion at the end of Q2 of fiscal 2026 and extends through 2040. It is divided between $3.7 billion in the LEU segment and $0.8 billion in Technical Solutions and includes approximately $3 billion of LEU and HALEU enrichment sales. Of this latter amount, $2.4 billion is under definitive agreements, while the quarterly increase of approximately $600 million came from commercial agreements rather than the Department of Energy task order.
On August 6, 2026, Centrus announced a definitive contract to provide LEU and HALEU enrichment services to X-energy in support of Xe-100 reactors and TRISO-X fuel, without disclosing delivery dates or prices. It also signed a letter of intent with Oklo to supply up to five Aurora facilities with HALEU fuel for several years beginning in 2029, but the letter of intent precedes a definitive agreement. Management says HALEU commitments generally include prepayments, which could provide non-debt, non-dilutive financing for capacity expansion.
Management is targeting placing the first new capacity into service during 2029, without committing to moving the date forward. During fiscal 2026, the company plans to complete the first centrifuge at the Oak Ridge facility, then ship centrifuges to Piketon for installation and preparation to begin enrichment. It is also working with the Department of Energy on arrangements that would permit the temporary commercial operation of the existing 16-centrifuge HALEU cascade.
Net income declined to $16.8 million from $28.9 million in Q2 of fiscal 2025, despite a 14% increase in revenue. The company attributed the decline primarily to a $12.8 million increase in selling, general, and administrative expenses, driven by higher stock-based compensation, and a $7.5 million increase in advanced technology costs. Advanced technology expenses were $10.6 million and stock-based compensation was $17.7 million, while an $8.3 million increase in investment income offset part of the pressure.
Centrus reaffirmed its fiscal 2026 revenue guidance of between $450 million and $500 million, with total capital expenditures between $350 million and $500 million. It raised its net hiring target in Piketon from more than 100 to more than 175 employees, while targeting the addition of at least 100 net employees in Oak Ridge. The targets also include entering into contracts with 100% of suppliers classified as critical, issuing an approved-for-construction package, and completing the first centrifuge in Oak Ridge during fiscal 2026.
